Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 106 AL 120

Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation

Regen F, Hellmann-Regen J, Costantini E, Reale M.

Curr Alzheimer Res. 2017;14(11):1140-1148. doi: 10.2174/1567205014666170203141717.

Nutrition and AGE-ing: Focusing on Alzheimer's Disease

Abate G, Marziano M, Rungratanawanich W, Memo M, Uberti D.

Oxid Med Cell Longev. 2017;2017:7039816. doi: 10.1155/2017/7039816. Epub 2017 Jan 12.

Correlation of rs9331888 polymorphism with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review

Zhu B, Wang RM, Wang JT, Chen RL, Zheng YF, Zhang L, Zhao ZG.

Metab Brain Dis. 2017 Aug;32(4):981-989. doi: 10.1007/s11011-017-9957-8. Epub 2017 Feb 6.

Molecular Targets of Tannic Acid in Alzheimer's Disease

Braidy N, Jugder BE, Poljak A, Jayasena T, Nabavi SM, Sachdev P, Grant R.

Curr Alzheimer Res. 2017;14(8):861-869. doi: 10.2174/1567205014666170206163158.

Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses

Kamal MA, Shakil S, Nawaz MS, Yu QS, Tweedie D, Tan Y, Qu X, Greig NH.

CNS Neurol Disord Drug Targets. 2017;16(7):820-827. doi: 10.2174/1871527316666170207160606.

Association of premorbid personality with behavioral and psychological symptoms in dementia with Lewy bodies: Comparison with Alzheimer's disease patients

Tabata K, Saijo Y, Morikawa F, Naoe J, Yoshioka E, Kawanishi Y, Nakagi Y, Yoshida T.

Psychiatry Clin Neurosci. 2017 Jun;71(6):409-416. doi: 10.1111/pcn.12511. Epub 2017 Mar 30.

Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance

Quittot N, Sebastiao M, Bourgault S.

Biochem Cell Biol. 2017 Jun;95(3):329-337. doi: 10.1139/bcb-2016-0236. Epub 2017 Feb 1.

Alzheimer's disease in the zebrafish: where can we take it?

Caramillo EM, Echevarria DJ.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):179-186. doi: 10.1097/FBP.0000000000000284.

The contribution of transgenic and nontransgenic animal models in Alzheimer's disease drug research and development

Mhillaj E, Cuomo V, Mancuso C.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):95-111. doi: 10.1097/FBP.0000000000000296.

Interactions of Mitochondria/Metabolism and Calcium Regulation in Alzheimer's Disease: A Calcinist Point of View

Gibson GE, Thakkar A.

Neurochem Res. 2017 Jun;42(6):1636-1648. doi: 10.1007/s11064-017-2182-3. Epub 2017 Feb 8.

Solid-State Structure of Abeta (Aβ) in Alzheimer's Disease

Lu JX, Dong XQ, Zhang JJ.

Protein Pept Lett. 2017;24(4):322-330. doi: 10.2174/0929866524666170208155108.

Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease

Liew LC, Katsuda T, Gailhouste L, Nakagama H, Ochiya T.

Int Immunol. 2017 Jan 1;29(1):11-19. doi: 10.1093/intimm/dxx002.

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial

Morris JK, Vidoni ED, Johnson DK, Van Sciver A, Mahnken JD, Honea RA, Wilkins HM, Brooks WM, Billinger SA, Swerdlow RH, Burns JM.

PLoS One. 2017 Feb 10;12(2):e0170547. doi: 10.1371/journal.pone.0170547. eCollection 2017.

Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease

Franco R, Martínez-Pinilla E, Navarro G, Zamarbide M.

Prog Neurobiol. 2017 Feb-Mar;149-150:21-38. doi: 10.1016/j.pneurobio.2017.01.004. Epub 2017 Feb 9.

Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms

Kerr JS, Adriaanse BA, Greig NH, Mattson MP, Cader MZ, Bohr VA, Fang EF.

Trends Neurosci. 2017 Mar;40(3):151-166. doi: 10.1016/j.tins.2017.01.002. Epub 2017 Feb 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias